Your browser doesn't support javascript.
loading
Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study.
Miyamoto, Satoshi; Heerspink, Hiddo J L; de Zeeuw, Dick; Toyoda, Masao; Suzuki, Daisuke; Hatanaka, Takashi; Nakamura, Tohru; Kamei, Shinji; Murao, Satoshi; Hida, Kazuyuki; Ando, Shinichiro; Akai, Hiroaki; Takahashi, Yasushi; Koya, Daisuke; Kitada, Munehiro; Sugano, Hisashi; Nunoue, Tomokazu; Nakamura, Akihiko; Sasaki, Motofumi; Nakatou, Tatsuaki; Fujimoto, Kei; Kawanami, Daiji; Wada, Takashi; Miyatake, Nobuyuki; Yoshida, Michihiro; Shikata, Kenichi.
Afiliação
  • Miyamoto S; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Toyoda M; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
  • Suzuki D; Suzuki Diadetes Clinic, Atsugi, Japan.
  • Hatanaka T; Department of Diabetes and Endocrinology, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan.
  • Nakamura T; Diabetes Internal Medicine, Sumitomo Besshi Hospital, Nihama, Japan.
  • Kamei S; Department of Diabetic Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Murao S; Department of Diabetes and Endocrinology, Takamatsu Hospital, Takamatsu, Japan.
  • Hida K; Department of Diabetology and Metabolism, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Ando S; Department of Internal Medicine Diabetic Center, Okayama City Hospital, Okayama, Japan.
  • Akai H; Division of Diabetes and Metabolism, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Takahashi Y; Department of Diabetes, Ochiai General Hospital, Maniwa, Japan.
  • Koya D; Department of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Japan.
  • Kitada M; Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, Uchinada, Japan.
  • Sugano H; Omi Medical Center, Kusatsu, Japan.
  • Nunoue T; Department of Diabetology and Endocrinology, Kanazawa Medical University, Uchinada, Japan.
  • Nakamura A; Division of Anticipatory Molecular Food Science and Technology, Medical Research Institute, Kanazawa Medical University, Uchinada, Japan.
  • Sasaki M; Department of Diabetes and Endocrinology, Kochi Health Sciences Center, Kochi, Japan.
  • Nakatou T; Nunoue Clinic, Tsuyama, Japan.
  • Fujimoto K; Internal Medicine, Osafune Clinic, Setouchi, Japan.
  • Kawanami D; Department of Diabetes and Endocrinology, Matsue City Hospital, Matsue, Japan.
  • Wada T; Diabetes Center, Okayama Saiseikai General Hospital, Okayama, Japan.
  • Miyatake N; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Kashiwa, Japan.
  • Yoshida M; Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, Fukuoka, Japan.
  • Shikata K; Department of Nephrology and Laboratory Medicine, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Diabetes Obes Metab ; 24(8): 1429-1438, 2022 08.
Article em En | MEDLINE | ID: mdl-35491532
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão